Transforming REMS Surveys with Flexible and Cost Effective Solutions
Overview The Client A leading global clinical research organization (CRO) aimed to conduct Risk Evaluation and Mitigation Strategy (REMS) surveys—an essential process for ensuring the safe use of medications with serious risks. However, they faced challenges in finding a reliable partner with the expertise to navigate the specific REMS survey requirements while ensuring compliance with... Read More
10 Tips & Tricks to Optimize Data Capture in your next Clinical Trial
Join us on August 11th to learn expert tips for enhancing clinical trial data capture. Register now to save your seat or access the recording later!
EvidentIQ Q&A
Dacima Software’s ownership change, effective July 1, 2022, brings faster growth, an expanded global presence, and exciting new product developments—while maintaining existing studies, agreements, and service quality. Contact Dr. John Podoba for more details.
Dacima has joined the EvidentIQ Group
As of July 1, 2022, Dacima is part of the EvidentIQ Group, enhancing our global reach and innovation while maintaining our team, name, and commitment to excellence. Business continues as usual!
Happy Holidays
DACIMA team wishes you a happy holiday and healthy New Year! The past year has not been easy for everyone. We are so grateful for your continued support and partnership.
Results of COLCORONA study on ways to prevent morbidity and mortality related to COVID-19
The Montreal Heart Institute has released results from the COLCORONA study on reducing COVID-19 morbidity and mortality. Dacima is proud to have been a technology partner in this critical clinical trial.
Movember to Launch World’s First Cancer Registry ‘Super Network’
Movember is creating the world’s largest prostate cancer patient registry network, harnessing real-world data from over 130,000 men to transform treatment and care. In a landmark partnership, Dacima Software will design a cutting-edge registry database, integrating global patient data for improved outcomes, faster clinical trials, and personalized care.
Coronavirus outbreak and potential impact on clinical data
Dacima collaborates with research institutes and government agencies to enhance healthcare services during the COVID-19 pandemic. Our secure, efficient, and cost-effective EDC platform accelerates outbreak research and response with accurate data collection and analytics.
Double-Blind, Single-Center, Randomized Three-Way Crossover Trial of Fitted, Thin, and Standard Condoms for Vaginal and Anal Sex: C-PLEASURE Study Protocol and Baseline Data
Emory University utilized Dacima Clinical Suite for its groundbreaking C-Pleasure study, published in JMIR. This first-of-its-kind trial compared the performance, pleasure, and preferences of fitted, thin, and standard condoms to improve sexual health outcomes.
